fda compounding semaglutide enforcement 2025 news What Patients Need to Know About the GLP-1 Policy Changes Compounding pharmacies to halt semaglutide

This is why some clinicians, including Paloma health care providers who prescribe GLP-1 drugs, monitor thyroid function more closely after initiating a GLP-1

Over two-thirds (67%) of Americans say they would prefer to stay at a job they don't like rather than start a new job, just to keep insurance coverage for weight loss medications

Unfortunately, both carrying excess weight and using GLP-1 medications for weight loss carry a stigma

The regulatory and supply landscape for retatrutide and semaglutide could not be more different right now, and these practical realities will determine which option is available to most people for the foreseeable future

Anyone who has used an unlicensed product labelled as retatrutide should seek medical advice if side effects are severe, persistent or worsening

GIP also stimulates bone formation and inhibits bone resorption [38], but we dont have any clinical evidence to date of an effect on bone preservation with a GLP- 1/GIP dual agonist for weight loss